Cypherpunk Technologies Inc. CYPH

FY2021 · ended Dec 31, 2021 · Revenue $1.50M, +0.0% YoY · Filed Mar 24, 2023

Cypherpunk Technologies Inc. (CYPH) files with the SEC under industry code 2834, Pharmaceutical Preparations. As of Jun 30, 2026 it held $7.6 million in cash and investments and $38,000 in total debt.

Revenue
$1.50M
+0.0% vs prior year
Net income
$4.82M
+107.1% vs prior year
Operating cash flow (TTM)
$-21.06M
+64.9% vs year-ago TTM
Free cash flow
$-27.00M
-21.6% vs prior year
EPS
$0.07
+103.9% vs prior year
Dividend per share
None
Shares outstanding
89.98M
+118.1% vs prior year
Net cash
$7.59M
as of Jun 30, 2026
Operating margin
-2761.7%
FY 2021

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
CYPH (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Cambridge, MA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1509745
Former names
LEAP THERAPEUTICS, INC. (until Nov 12, 2025); Dekkun Corp (until Jan 7, 2011)

Other Pharmaceutical Preparations companies

Key figures

Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.

Line
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
Revenue
—
—
—
—
$1.5M
Operating income
-$41.1M
-$70.1M
-$87.0M
-$56.8M
-$41.4M
Net income
$4.8M
-$67.6M
-$81.4M
-$54.6M
-$40.6M
Diluted EPS
$0.07
-$1.81
-$3.98
-$4.82
-$0.47
Operating cash flow
-$43.9M
-$60.3M
-$43.8M
-$49.0M
-$35.2M
Total assets
$163.2M
$49.1M
$72.8M
$70.4M
$117.9M
Total liabilities
$9.7M
—
$12.7M
$11.5M
$10.0M
Stockholders' equity
$153.5M
$35.0M
$60.1M
$58.9M
$107.9M
Cash and investments
$14.0M
$47.2M
$70.6M
$65.5M
$114.9M
Total debt
$38,000
$266,000
$262,000
$678,000
$469,000

Recent SEC filings

Recent SEC filings
Form Description Filed Period
8-K Current report
Officer or director change, Regulation FD disclosure
Sep 22, 2026 Sep 22, 2026
8-K Current report
Other events
Sep 2, 2026 Sep 2, 2026
8-K Current report
Material agreement, Unregistered share sale, Other events
Aug 18, 2026 Aug 17, 2026
10-Q Quarterly report Aug 12, 2026 Jun 30, 2026
8-K Current report
Results of operations, Other events
Aug 12, 2026 Aug 12, 2026
8-K Current report
Listing notice
Jul 21, 2026 Jul 20, 2026

Source: SEC EDGAR filings. This is company-reported data, not investment advice.